ECONOMIC BURDEN OF INVASIVE MENINGOCOCCAL DISEASE IN INDIVIDUALS WITH COMMERCIAL AND MEDICARE INSURANCE IN THE UNITED STATES

被引：0
|
作者：
Herrera-Restrepo, O. [1 ]
Kwiatkowska, M. [2 ]
Huse, S. [3 ]
Kocaata, Z. [4 ]
Ganz, M. [5 ]
机构：
[1] GSK, Springfield, VA USA
[2] Evidera, London, England
[3] Evidera, Cambridge, MA USA
[4] GSK, Wavre, Belgium
[5] Evidera, Waltham, MA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EPH133
引用
收藏
页码：S178 / S178
页数：1
相关论文
共 50 条
  • [1] INVASIVE MENINGOCOCCAL DISEASE RISK FACTORS IN INDIVIDUALS WITH COMMERCIAL AND MEDICARE INSURANCE IN THE UNITED STATES
    Herrera-Restrepo, O.
    Kwiatkowska, M.
    Huse, S.
    Kocaata, Z.
    Ganz, M.
    VALUE IN HEALTH, 2024, 27 (06) : S169 - S169
  • [2] The Burden of Infant Meningococcal Disease in the United States
    Judelsohn, R.
    Marshall, G. S.
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2012, 1 (01) : 64 - 73
  • [3] INVASIVE MENINGOCOCCAL DISEASE ECONOMIC BURDEN: A COMPREHENSIVE ANALYSIS
    Langevin, E.
    Lesage, H.
    Juniper, M.
    VALUE IN HEALTH, 2023, 26 (12) : S198 - S198
  • [4] CLINICAL AND ECONOMIC BURDEN OF INVASIVE MENINGOCOCCAL DISEASE IN FRANCE
    Fievez, S.
    Htar, Tin Tin M.
    Goguillot, M.
    Benard, S.
    Huang, L.
    VALUE IN HEALTH, 2018, 21 : S224 - S225
  • [5] Prevention of Invasive Meningococcal Disease in the United States
    Pelton, Stephen I.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2009, 28 (04) : 329 - 332
  • [6] Health economic burden of invasive meningococcal disease in the US
    Möller, J
    Getsios, D
    Caro, J
    El-Hadi, W
    O'Brien, JA
    Chevat, C
    Coudeville, L
    Nguyen, VH
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2005, 161 (11) : S99 - S99
  • [7] Economic and Disease Burden Associated with Invasive Escherichia coli Disease in the United States
    Mark A. Schmidt
    Maxim Blum
    Judy L. Donald
    Richard T. Meenan
    Elvira Carrió
    Jan Poolman
    Maureen P. Neary
    Thomas Verstraeten
    Jeroen Geurtsen
    Infectious Diseases and Therapy, 2025, 14 (3) : 569 - 586
  • [8] ECONOMIC BURDEN FOR ADULTS WITH SICKLE CELL DISEASE AND MATCHED CONTROLS IN THE UNITED STATES: RETROSPECTIVE ANALYSIS OF A COMMERCIAL INSURANCE DATABASE
    Barcelos, G. T.
    Peixoto, T.
    Alvir, J.
    Lingohr-Smith, M.
    Lin, J.
    Baker, C. L.
    VALUE IN HEALTH, 2024, 27 (06) : S82 - S82
  • [9] The economic burden of NIPC and BOS following allogeneic HSCT in patients with commercial insurance in the United States
    Sacks, Naomi C.
    Healey, Bridget E.
    Raza, Sajjad
    Cyr, Philip L.
    Boerner, Gerhard
    Sheshadri, Ajay
    BLOOD ADVANCES, 2022, 6 (05) : 1566 - 1576
  • [10] Understanding the Sequelae of Invasive Meningococcal Disease in the United States
    Marshall, Gary S.
    McCormick, Zachary L.
    Johns, Jeffery S.
    Verduzco-Gutierrez, Monica
    Herrera-Restrepo, Oscar
    Harrison, Lee H.
    INFECTIOUS DISEASES AND THERAPY, 2024, : 2213 - 2220
12345